Sertraline Induced Acute Hepatitis: A Case Report

HTML  XML Download Download as PDF (Size: 810KB)  PP. 476-480  
DOI: 10.4236/health.2015.74056    6,046 Downloads   9,619 Views  Citations

ABSTRACT

Depression is a common disorder amongst the general population and frequently encountered by most physicians. Selective Serotonin Re-Uptake Inhibitors (SSRI’s) have become the most commonly prescribed antidepressants due to their superiority compared with other antidepressants in the treatment of acute major depression. Although exceedingly rare, hepatotoxicity resulting from sertraline use has been previously reported. In these case reports, the liver injury pattern was predominately hepatocellular. Unlike previous cases, we report the case of a patient presenting with markedly elevated cholestatic enzymes and painless jaundice while taking sertraline for treatment of depression.

Share and Cite:

Abdullah, A. , Ibrahim, A. and Ahmed, H. (2015) Sertraline Induced Acute Hepatitis: A Case Report. Health, 7, 476-480. doi: 10.4236/health.2015.74056.

Copyright © 2024 by authors and Scientific Research Publishing Inc.

Creative Commons License

This work and the related PDF file are licensed under a Creative Commons Attribution 4.0 International License.